Medicare Part D coverage · ethacrynic acid · RxCUI 1251903
ethacrynic acid 25 MG Oral Tablet
Per the CMS 2026 Part D formulary file, ethacrynic acid 25 MG Oral Tablet is covered by 1,093 Medicare Part D plans (21.6% of enrollable products), averaging Tier 3.5, with prior authorization required on 5.9% of covering formularies.
- 21.6%
- Plan coverage
- 1,093
- Plans covering
- T3.5
- Avg tier
- 5.9%
- Prior auth required
What the CMS Formulary Data Shows for ethacrynic acid 25 MG Oral Tablet
Per the CMS 2026 Part D formulary file, ethacrynic acid 25 MG Oral Tablet (RxNorm concept RXCUI 1251903, generic name ethacrynic acid) appears on 34 distinct formulary files spanning 1,093 Medicare Part D plan offerings - 21.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.5.
Real-world access to ethacrynic acid 25 MG Oral Tablet depends on utilization management as much as tier placement: 5.9% of covering formularies require prior authorization. 0% require step therapy. 17.6% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 3,813 Part D beneficiaries filled ethacrynic acid 25 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $7,829,480 and an average per-beneficiary annual cost of $2,053.36. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry ethacrynic acid 25 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 34
- Plans covering
- 1,093
- Coverage rate
- 21.6%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 5.9% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 17.6% of formularies
2023 Medicare Spending
- Beneficiaries
- 3,813
- Total spending
- $7,829,480
- Avg per beneficiary
- $2,053.36
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering ethacrynic acid 25 MG Oral Tablet
2 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T4 | No | No | $0 | - |
| AARP Medicare Rx Preferred from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T4 | No | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering ethacrynic acid 25 MG Oral Tablet
98 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | No | $0 | MA |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Tufts Health One Care (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health One Care CW (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options CW (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| FHCP Medicare Classic (HMO) | Florida Blue Medicare, Inc. | T2 | No | $0 | FL |
| FHCP Medicare Rx Plus (HMO-POS) | Florida Blue Medicare, Inc. | T2 | No | $49.00 | FL |
| Freedom VIP Care (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom VIP Savings (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom VIP Savings (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom VIP Rewards (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom VIP Rewards (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Optimum Diamond Rewards (HMO C-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Diamond Savings (HMO C-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Diamond Rewards (HMO C-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Diamond (HMO C-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Freedom Medi-Medi Partial (HMO D-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Medi-Medi Full (HMO D-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
Show the next 30 plans
| Optimum Emerald Partial (HMO D-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Emerald Full (HMO D-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Freedom Medicare Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Medicare Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom VIP Savings COPD (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom VIP Savings COPD (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Rewards Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Rewards Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Rewards Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Rewards Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Rewards Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Rewards Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Máximo (HMO-POS) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Máximo (HMO-POS) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Optimum Gold Rewards Plan (HMO) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Platinum Plan (HMO) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Gold Plan (HMO) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Gold Rewards Plan (HMO) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Gold Rewards Plan (HMO) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Diamond Rewards COPD (HMO C-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Diamond Savings COPD (HMO C-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Gold Plus Plan (HMO) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Diamond Rewards COPD (HMO C-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| UHC Dual Complete IA-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T4 | No | $0 | IA |
| UHC Dual Complete MO-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T4 | No | $0 | MO |
Showing top 50 of 98 plans.
Frequently Asked Questions
Is ethacrynic acid 25 MG Oral Tablet covered by Medicare Part D?
Yes, ethacrynic acid 25 MG Oral Tablet is covered by 1,093 Medicare Part D plans (21.6% of all Part D formularies).
What tier is ethacrynic acid 25 MG Oral Tablet on Medicare Part D plans?
ethacrynic acid 25 MG Oral Tablet averages Tier 3.5 across Part D plans, ranging from Tier 1 to Tier 4.
Does ethacrynic acid 25 MG Oral Tablet require prior authorization?
5.9% of Part D formularies require prior authorization for ethacrynic acid 25 MG Oral Tablet. Step therapy: 0%. Quantity limits: 17.6%.
How much does Medicare spend on ethacrynic acid 25 MG Oral Tablet?
In 2023, total Medicare Part D spending on ethacrynic acid 25 MG Oral Tablet was $7,829,480, covering 3,813 beneficiaries. The average spend per beneficiary was $2,053.36.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- lomustine 40 MG Oral Capsule T3.5
- 1 ML denosumab 60 MG/ML Prefilled Syringe [Prolia] T3.5
- tretinoin 0.001 MG/MG Topical Gel T3.5
- daridorexant 25 MG Oral Tablet [Quviviq] T3.5
- 24 HR canagliflozin 150 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Invokamet] T3.5
- canagliflozin 150 MG / metformin hydrochloride 1000 MG Oral Tablet [Invokamet] T3.5
Similar prior-authorization rate
- naloxone 0.5 MG / pentazocine 50 MG Oral Tablet 5.9% PA
- nimodipine 3 MG/ML Oral Solution 5.9% PA
- protriptyline hydrochloride 10 MG Oral Tablet 5.8% PA
- ursodiol 200 MG Oral Capsule 5.8% PA
- meropenem 500 MG Injection 6.1% PA
- meropenem 1000 MG Injection 6.1% PA